Nanomics provides an AI‑enhanced proteomics platform that combines the Proteonano™ high‑throughput system, Nanomation™ automated liquid‑handling robots, and magnetic‑nanoparticle enrichment kits to process up to 300 samples per day with deep protein coverage (1,000‑5,000 proteins per plasma run) and low variability (CV < 15%). The integrated solution includes automated sample preparation, seamless LC‑MS integration, and AI‑driven data analysis, offering turnkey services for biomarker discovery, drug target identification, and precision‑medicine research.
Funding
Funding not disclosed
Founders
Product
Problem
Researchers and clinicians face bottlenecks in proteomics due to low‑throughput sample preparation, limited sensitivity for low‑abundance proteins, and high variability across large cohorts, which hampers biomarker discovery and precision‑medicine studies.
Solution
Nanomics delivers an integrated, AI‑enhanced proteomics ecosystem that combines the Proteonano™ Ultraplex high‑throughput platform, Nanomation™ automated liquid‑handling robots, and a suite of magnetic‑nanoparticle enrichment kits. The system processes up to 300 samples per day, achieving 1,000–5,000 protein identifications per plasma run with a dynamic range spanning nine orders of magnitude and coefficient‑of‑variation below 15 %. AI‑driven data pipelines provide unbiased quantification, quality‑control monitoring for each sample, and downstream analytics for biomarker and drug‑target discovery. The offering includes turnkey services (Autolab) that handle sample collection, enrichment, LC‑MS/MS, and report generation, enabling researchers to focus on interpretation rather than manual workflow management.
Target Audience
Primary customers are academic and industry research labs, clinical genomics and biomarker programs, and pharmaceutical R&D teams that require high‑throughput, deep proteome coverage for large‑scale studies.
Features
- Fully automated Nanomation™ G1 robots (basic and pro configurations) with 8‑channel pipetting, magnetic‑bead handling, heating, and visual touch‑screen control, capable of processing 96–300 samples per day
- Proteonano™ magnetic nanobead kits with AI‑selected ligands, providing up to 100‑fold higher sensitivity for low‑abundance plasma, serum, CSF, urine, and tissue samples
- Ultraplex proteomics platform that identifies 4,000–5,000 proteins per plasma run, covering a 9‑log dynamic range and achieving median CV < 15 %
- Built‑in quality‑control system (QCS) that monitors enrichment efficiency and instrument performance for each individual sample
- Seamless integration with major high‑resolution LC‑MS instruments (Orbitrap Astral, Orbitrap 480, tims‑TOF) without additional hardware
- AI‑powered data analysis suite that performs peptide identification, quantification, statistical validation, and functional annotation in a single workflow
- Scalable service model (Autolab) offering end‑to‑end proteomics for large cohorts, including sample logistics, data delivery, and customizable reporting